Advocacy Actions
Policy Briefing on Yangshan Special Comprehensive Bonded Zone
Policy Briefing on Yangshan Special Comprehensive Bonded Zone
Read moreComments to the NMPA on the Supporting Documents of the Drug Registration Regulation
Comments to the NMPA on the Supporting Documents of the Drug Registration Regulation
Read moreComments on the Supporting Documents to the Drug Administration Regulation to the National Medical Products Administration
European Chamber Pharmaceutical working group submitted comments on the Supporting Documents to the Drug Administration Regulation to the National Medical Products Administration
Read moreComments to SPC on Guidelines for Enforcement of Intellectual Property Decisions (Draft for Comment)
The European Chamber very much welcomes the Supreme People's Court's decision to collect opinions on the "Guidelines for Enforcement of Intellectual Property Decisions (Draft for Comment)". Upon careful study of the draft and consultation with its members, the European Union Chamber of Commerce in China, led by its Intellectual Property Rights Working Group, has collated all member inputs and submitted suggestions to the SPC for their consideration.
Read moreComments to the NHSA on the Interim Administrative Measures of Drug Use for Basic Medical Insurance (Draft for Comments)
Comments to the NHSA on the Interim Administrative Measures of Drug Use for Basic Medical Insurance (Draft for Comments)
Read moreComments to MOFCOM on Measures for the Handling of Complaints from Foreign-invested Enterprises (Draft for Comment)
The European Chamber very much welcomes the MOFCOM's decision to collect opinions on the "Measures for the Handling of Complaints from Foreign-invested Enterprises (Draft for Comment)". Upon careful study of the draft and consultation with its members, the European Union Chamber of Commerce in China, led by its Legal and Compliance Working Group, has collated all member inputs and submitted suggestions to the MOFCOM for their consideration.
Read moreComments to MOFCOM and NDRC on Catalogue of Industries for Encouraged Foreign Investment (2019)
The European Chamber very much welcomes the MOFCOM's decision to collect opinions on the "Catalogue of Industries for Encouraged Foreign Investment (2019)". Upon careful study of the draft and consultation with its members, the European Union Chamber of Commerce in China has collated all member inputs and submitted suggestions to the MOFCOM for their consideration.
Read moreLobby Letter to Shanghai Municipal Commission of Commerce and Shanghai Health Commission on the Current Situation of Corona Virus
On 5 March, the Medical Device Sector and Pharmaceutical (Pharma) Working Group jointly sent a lobby letter to Shanghai Municipal Commission of Commerce and Shanghai Health Commission the current situation of Corona Virus.
Read moreComments to SAMR on Draft Revisions to the Anti-monopoly Law of the People's Republic of China (Draft for Comment)
The European Chamber very much welcomes the SAMR's decision to collect opinions on the "Draft Revisions to the Anti-monopoly Law of the People's Republic of China (Draft for Comment)". Upon careful study of the draft and consultation with its members, the European Union Chamber of Commerce in China, led by its Legal and Compliance Working Group, has collated all member inputs and submitted suggestions to the SAMR Anti-monopoly Bureau for their consideration.
Read moreComments to CNIPA on Criteria for the Determination of Trademark Infringement (Draft for Comment)
The European Chamber very much welcomes the CNIPA's decision to collect opinions on the "Criteria for the Determination of Trademark Infringement (Draft for Comment)". Upon careful study of the draft and consultation with its members, the European Union Chamber of Commerce in China, led by its IPR Working Group, has collated all member inputs and submitted suggestions to the CNIPA for their consideration.
Read more